BlackThorn Therapeutics
About:
BlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.
Website: http://www.blackthornrx.com/
Twitter/X: blackthornrx
Top Investors: Alexandria Real Estate Equities, Mercury, Google Ventures, Polaris Partners, Alexandria Venture Investments
Description:
BlackThorn Therapeutics operator of a clinical-stage biopharmaceutical company intended to develop precision medicine for disorders of the central nervous system (CNS) based on advances in computational and clinical neuroscience. The company leverages a deep understanding of brain and behavior relationships that seeks to overcome historic challenges in drug discovery and development by targeting dysfunctional brain circuits. Its proprietary computational platform, the company seeks to identify novel targets, small molecule drug candidates and biologically-based patient subgroups most likely to respond to treatment.
$138M
$1M to $10M
San Francisco, California, United States
2015-01-01
info(AT)blackthornrx.com
Alex Tkachenko, Bill Martin, Ed Roberts
11-50
2019-06-13
Private
© 2024 MyAiNote.com